Home > Insider Trading > Filing (0001127602-11-008799)

Filing Details

Accession Number:: 0001127602-11-008799
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-03-03 18:32:41
Reporting Period:: 2011-03-01

Filing Date:: 2011-03-03
Accepted Time:: 2011-03-03 18:32:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1145197	Insulet Corp	PODD	Surgical & Medical Instruments & Apparatus (3841)	043523891

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1395780	Ruthann Depietro	C/O Insulet Corporation 9 Oak Park Drive Bedford MA 01730	Vice President Of Quality	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-03-01	8,000	$0.00	16,420	No	4	A	Direct
Common Stock	Acquisiton	2011-03-01	1,500	$5.94	17,920	No	4	M	Direct
Common Stock	Disposition	2011-03-01	847	$17.49	17,073	No	4	F	Direct
Common Stock	Disposition	2011-03-01	1,500	$17.74	15,573	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2011-03-01	8,000	$0.00	8,000	$17.49
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2011-03-01	1,500	$0.00	1,500	$5.94

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,000		2021-03-01	No	4	A	Direct
56,641		2016-03-06	No	4	M	Direct

Footnotes

The 8,000 restricted stock units vest one-third of the total units on the first anniversary date of the grant and one-third each on the second and third anniversaries of the date of the grant. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
This option may be exercised at any time, whether vested or not, but, upon termination of employment, we may repurchase any unvested shares at the exercise price paid for the shares. This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal monthly installments each month thereafter for 36 months, subject to continued employment.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2010.
This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.
Includes 5,334 restricted stock units granted on March 1, 2010 which vest one-half on March 1, 2012 and one-half on March 1, 2013. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
Includes an aggregate of 420 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan: 20 shares acquired on December 31, 2007; 48 shares acquired on June 30, 2008; 100 shares acquired on December 31, 2008; 99 shares acquired on June 30, 2009; 53 shares acquired on December 31, 2009; 51 shares acquired on June 30, 2010; and 49 shares acquired on December 31, 2010.